Department of Internal Medicine, Baylor Scott and White Health, Temple, Texas, USA.
Texas A&M Health Sciences Center College of Medicine, Temple, Texas, USA.
Am J Nephrol. 2022;53(11-12):794-805. doi: 10.1159/000529112. Epub 2023 Jan 13.
Like metabolic acidosis, earlier stages of acid (H+) stress, including an ongoing H+ challenge in the form of dietary H+, without or with steady-state H+ accumulation but with normal plasma total CO2 (PTCO2) (the latter state known as eubicarbonatemic acidosis), are associated with augmented progression of chronic kidney disease (CKD), but diagnosis of this covert H+ stress is clinically problematic. Prior published studies to identify clinically practical biomarkers of covert H+ stress did not include assessments of either dietary H+ or H+ retention.
We tested plasma pH (PpH), 8-h urine excretion of citrate (UcitV) or ammonium (UNH4+V) as biomarkers of dietary H+ assessed as potential renal acid load (PRAL), and of steady-state H+ retention by comparing observed to expected PTCO2 increase 2 h after an oral NaHCO3 bolus. We recruited 313 non-diabetic participants with PTCO2 ≥ 22 mM to exclude participants with metabolic acidosis and with eGFR (mean [SD], mL/min/1.73 m2) stages G1 (n = 62, 99.2 [7.3]), G2 (n = 167, 73.8 [6.3]), and G3 (n = 84, 39.9 [6.7]). We performed linear regressions (LR) between H+ retention or PRAL (dependent variables) and PpH, UcitV, or UNH4+V (independent variables) after adjusting for eGFR.
Steady-state H+ retention (mean [SD], mmol) increased with stage (G1 = 3.8 [12.5], G2 = 18.2 [12.4], and G3 = 25.6 [9.0]). PpH was not significantly associated with PRAL in any group, and its association with H+ retention was significant only for G3 (p < 0.01). UcitV association with PRAL was significant only for G1 (p < 0.01) but not for G2 (p = 0.65) or G3 (p = 0.11). UcitV association with H+ retention was negative for both G2 (p < 0.01) and G3 (p < 0.01) but was not significant for G1 (p = 0.50). Adding UNH4+V to UcitV as a regressor for H+ retention increased r2 only marginally for G2 (0.61-0.63) and G3 (0.75-0.79). UNH4+V association with PRAL was positive (p < 0.01) for G1 and G2 but was not significant for G3 (p = 0.46). UNH4+V association with H+ retention was significant for both G2 (p < 0.04) and G3 (p < 0.01) but diverged directionally, being positive for G2 but negative for G3.
Among patients with CKD at risk for covert H+ stress, lower UcitV better identified eubicarbonatemic acidosis than UNH4+V because the UNH4+V versus H+ retention relationship diverged between G2 and G3. Neither test identified eubicarbonatemic acidosis with certainty, indicating need for further work to establish a clinically useful test. On the other hand, UNH4+V had better utility identifying increased dietary H+ assessed as PRAL in G1 and G2.
与代谢性酸中毒类似,酸(H+)应激的早期阶段,包括以膳食 H+形式持续存在的 H+挑战,没有或没有稳态 H+积累但有正常的血浆总 CO2(PTCO2)(后者状态称为碱血症伴正常阴离子间隙),与慢性肾脏病(CKD)的进展加速有关,但这种隐匿性 H+应激的诊断在临床上存在问题。之前发表的研究旨在确定隐匿性 H+应激的临床实用生物标志物,但没有包括对膳食 H+或 H+保留的评估。
我们测试了血浆 pH(PpH)、8 小时尿排泄的柠檬酸(UcitV)或铵(UNH4+V),作为潜在肾酸负荷(PRAL)评估的膳食 H+的生物标志物,以及通过比较口服 NaHCO3 冲击后 2 小时观察到的与预期的 PTCO2 增加来评估稳态 H+保留。我们招募了 313 名 PTCO2≥22mM 的非糖尿病参与者,以排除代谢性酸中毒和 eGFR(平均值[标准差],mL/min/1.73 m2)分期 G1(n=62,99.2[7.3])、G2(n=167,73.8[6.3])和 G3(n=84,39.9[6.7])的参与者。我们进行了线性回归(LR),在调整 eGFR 后,将 H+保留或 PRAL(因变量)与 PpH、UcitV 或 UNH4+V(自变量)进行了比较。
稳态 H+保留(平均值[标准差],mmol)随着分期增加(G1=3.8[12.5],G2=18.2[12.4],G3=25.6[9.0])而增加。PpH 与 PRAL 在任何组中均无显著相关性,其与 H+保留的相关性仅在 G3 中显著(p<0.01)。UcitV 与 PRAL 的相关性仅在 G1 中显著(p<0.01),但在 G2(p=0.65)或 G3(p=0.11)中不显著。UcitV 与 H+保留的相关性在 G2(p<0.01)和 G3(p<0.01)中均为负相关,但在 G1 中不显著(p=0.50)。将 UNH4+V 添加到 UcitV 作为 H+保留的回归因子,仅使 G2(0.61-0.63)和 G3(0.75-0.79)的 r2 略有增加。UNH4+V 与 PRAL 的相关性在 G1 和 G2 中均为正相关(p<0.01),但在 G3 中不显著(p=0.46)。UNH4+V 与 H+保留的相关性在 G2(p<0.04)和 G3(p<0.01)中均显著,但方向不同,在 G2 中为正,在 G3 中为负。
在有隐匿性 H+应激风险的 CKD 患者中,与 UNH4+V 相比,UcitV 能更好地识别碱血症伴正常阴离子间隙,因为 UNH4+V 与 H+保留的关系在 G2 和 G3 之间存在差异。两种检测方法均不能确定碱血症伴正常阴离子间隙的存在,这表明需要进一步研究以建立一种临床有用的检测方法。另一方面,UNH4+V 更好地识别了以 PRAL 评估的膳食 H+的增加,在 G1 和 G2 中。